The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment

NCT03855007 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Iguratimod
DRUG: MTX
DRUG: HCQ
DRUG: Pred

Sponsor

Qilu Hospital of Shandong University